APO Research
Talk to an analyst

APO RESEARCH · REPORT

Viscosupplementation Injection

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.

Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful.

Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.

Selected research

Market Structure

Global Viscosupplementation Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025193 pages

Choose your research edition.

Industry ResearchViscosupplementation Injection Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Viscosupplementation Injection Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Viscosupplementation Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Viscosupplementation Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Viscosupplementation Injection Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.

Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful.

Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.

Read the full market overview

The classification of Viscosupplementation Injection includes Single Injection, Three Injection, Five Injection, and the sales share of Single Injection take about 40%.

Viscosupplementation Injection is widely used in hospitals, clinics and other place. The most proportion of Viscosupplementation Injection used in Hospitals, and the proportion is 55%.

North America is the largest consumption place, with a consumption market share nearly 52%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 28%.

Sanofi, Bioventus, Seikagaku, Anika Therapeutics, LG Chem, Ferring, etc. are the leaders of the industry. Top six company with about 63% market share.

This report provides an overview of the global Viscosupplementation Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Viscosupplementation Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Viscosupplementation Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Viscosupplementation Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Viscosupplementation Injection Segment by Company

Sanofi

Anika Therapeutics

Seikagaku

Zimmer Biomet

Bioventus

Ferring

LG Chem

Freda

Haohai Biological

Shanghai Jingfeng

Viscosupplementation Injection Segment by Type

Single Injection

Three Injection

Five Injection

Viscosupplementation Injection Segment by Application

Hospitals

Clinics

Others

Viscosupplementation Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Viscosupplementation Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Viscosupplementation Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Viscosupplementation Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Viscosupplementation Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Viscosupplementation Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Viscosupplementation Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Viscosupplementation Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Viscosupplementation Injection Industry Trends Table 2. Viscosupplementation Injection Industry Drivers Table 3. Viscosupplementation Injection Industry Opportunities and Challenges Table 4. Viscosupplementation Injection Industry Restraints Table 5. Global Viscosupplementation Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Viscosupplementation Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Viscosupplementation Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Viscosupplementation Injection Sales Market Share by Manufacturers Table 9. Global Viscosupplementation Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Viscosupplementation Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Viscosupplementation Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Viscosupplementation Injection Manufacturers, Product Type & Application Table 13. Global Viscosupplementation Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Viscosupplementation Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Single Injection Table 17. Major Manufacturers of Three Injection Table 18. Major Manufacturers of Five Injection Table 19. Global Viscosupplementation Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Viscosupplementation Injection Sales by Type (2021-2026) & (K Units) Table 21. Global Viscosupplementation Injection Sales by Type (2027-2032) & (K Units) Table 22. Global Viscosupplementation Injection Sales Market Share by Type (2021-2026) Table 23. Global Viscosupplementation Injection Sales Market Share by Type (2027-2032) Table 24. Global Viscosupplementation Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Viscosupplementation Injection Revenue by Type (2021-2026) & (K Units) Table 26. Global Viscosupplementation Injection Revenue by Type (2027-2032) & (K Units) Table 27. Global Viscosupplementation Injection Revenue Market Share by Type (2021-2026) Table 28. Global Viscosupplementation Injection Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Others Table 32. Global Viscosupplementation Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Viscosupplementation Injection Sales by Application (2021-2026) & (K Units) Table 34. Global Viscosupplementation Injection Sales by Application (2027-2032) & (K Units) Table 35. Global Viscosupplementation Injection Sales Market Share by Application (2021-2026) Table 36. Global Viscosupplementation Injection Sales Market Share by Application (2027-2032) Table 37. Global Viscosupplementation Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Viscosupplementation Injection Revenue by Application (2021-2026) & (K Units) Table 39. Global Viscosupplementation Injection Revenue by Application (2027-2032) & (K Units) Table 40. Global Viscosupplementation Injection Revenue Market Share by Application (2021-2026) Table 41. Global Viscosupplementation Injection Revenue Market Share by Application (2027-2032) Table 42. Global Viscosupplementation Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Viscosupplementation Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Viscosupplementation Injection Sales Market Share by Region (2021-2026) Table 45. Global Viscosupplementation Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Viscosupplementation Injection Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Viscosupplementation Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Viscosupplementation Injection Sales by Country (2021-2026) & (K Units) Table 49. North America Viscosupplementation Injection Sales by Country (2027-2032) & (K Units) Table 50. Europe Viscosupplementation Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Viscosupplementation Injection Sales by Country (2021-2026) & (K Units) Table 52. Europe Viscosupplementation Injection Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Viscosupplementation Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Viscosupplementation Injection Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Viscosupplementation Injection Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Viscosupplementation Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Viscosupplementation Injection Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Viscosupplementation Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Viscosupplementation Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Viscosupplementation Injection Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Viscosupplementation Injection Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Viscosupplementation Injection Revenue Market Share by Region (2021-2026) Table 63. Global Viscosupplementation Injection Revenue Market Share by Region (2027-2032) Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Viscosupplementation Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Sanofi Viscosupplementation Injection Product Portfolio Table 68. Sanofi Recent Development Table 69. Anika Therapeutics Company Information Table 70. Anika Therapeutics Business Overview Table 71. Anika Therapeutics Viscosupplementation Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Anika Therapeutics Viscosupplementation Injection Product Portfolio Table 73. Anika Therapeutics Recent Development Table 74. Seikagaku Company Information Table 75. Seikagaku Business Overview Table 76. Seikagaku Viscosupplementation Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Seikagaku Viscosupplementation Injection Product Portfolio Table 78. Seikagaku Recent Development Table 79. Zimmer Biomet Company Information Table 80. Zimmer Biomet Business Overview Table 81. Zimmer Biomet Viscosupplementation Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Zimmer Biomet Viscosupplementation Injection Product Portfolio Table 83. Zimmer Biomet Recent Development Table 84. Bioventus Company Information Table 85. Bioventus Business Overview Table 86. Bioventus Viscosupplementation Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Bioventus Viscosupplementation Injection Product Portfolio Table 88. Bioventus Recent Development Table 89. Ferring Company Information Table 90. Ferring Business Overview Table 91. Ferring Viscosupplementation Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Ferring Viscosupplementation Injection Product Portfolio Table 93. Ferring Recent Development Table 94. LG Chem Company Information Table 95. LG Chem Business Overview Table 96. LG Chem Viscosupplementation Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. LG Chem Viscosupplementation Injection Product Portfolio Table 98. LG Chem Recent Development Table 99. Freda Company Information Table 100. Freda Business Overview Table 101. Freda Viscosupplementation Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Freda Viscosupplementation Injection Product Portfolio Table 103. Freda Recent Development Table 104. Haohai Biological Company Information Table 105. Haohai Biological Business Overview Table 106. Haohai Biological Viscosupplementation Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Haohai Biological Viscosupplementation Injection Product Portfolio Table 108. Haohai Biological Recent Development Table 109. Shanghai Jingfeng Company Information Table 110. Shanghai Jingfeng Business Overview Table 111. Shanghai Jingfeng Viscosupplementation Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Shanghai Jingfeng Viscosupplementation Injection Product Portfolio Table 113. Shanghai Jingfeng Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Viscosupplementation Injection Distributors List Table 117. Viscosupplementation Injection Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Viscosupplementation Injection Product Image Figure 2. Global Viscosupplementation Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Viscosupplementation Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Viscosupplementation Injection Sales (2021-2032) & (K Units) Figure 5. Global Viscosupplementation Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Viscosupplementation Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Single Injection Image Figure 9. Three Injection Image Figure 10. Five Injection Image Figure 11. Global Viscosupplementation Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Viscosupplementation Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Viscosupplementation Injection Sales Market Share by Type (2021-2032) Figure 14. Global Viscosupplementation Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Viscosupplementation Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Viscosupplementation Injection Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Others Image Figure 20. Global Viscosupplementation Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Viscosupplementation Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Viscosupplementation Injection Sales Market Share by Application (2021-2032) Figure 23. Global Viscosupplementation Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Viscosupplementation Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Viscosupplementation Injection Revenue Market Share by Application (2021-2032) Figure 26. North America Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Viscosupplementation Injection Sales Market Share by Country (2021-2032) Figure 28. U.S. Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Viscosupplementation Injection Sales Market Share by Country (2021-2032) Figure 33. Germany Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Viscosupplementation Injection Sales Market Share by Country (2021-2032) Figure 40. China Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Viscosupplementation Injection Sales Market Share by Country (2021-2032) Figure 48. Brazil Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Viscosupplementation Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Viscosupplementation Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Viscosupplementation Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Viscosupplementation Injection Revenue (2021-2032) & (US$ Million) Figure 59. North America Viscosupplementation Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Viscosupplementation Injection Revenue (2021-2032) & (US$ Million) Figure 61. Europe Viscosupplementation Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Viscosupplementation Injection Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Viscosupplementation Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Viscosupplementation Injection Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Viscosupplementation Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Viscosupplementation Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Viscosupplementation Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Single Injection
  • Three Injection
  • Five Injection
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Sanofi
  • Anika Therapeutics
  • Seikagaku
  • Zimmer Biomet
  • Bioventus
  • Ferring
  • LG Chem
  • Freda
  • Haohai Biological
  • Shanghai Jingfeng

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Viscosupplementation Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Viscosupplementation Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Viscosupplementation Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Viscosupplementation Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Viscosupplementation Injection Market Dynamics
  1. 2.1 Viscosupplementation Injection Industry Trends
  2. 2.2 Viscosupplementation Injection Industry Drivers
  3. 2.3 Viscosupplementation Injection Industry Opportunities and Challenges
  4. 2.4 Viscosupplementation Injection Industry Restraints
3 Viscosupplementation Injection Market by Manufacturers
  1. 3.1 Global Viscosupplementation Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Viscosupplementation Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Viscosupplementation Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Viscosupplementation Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Viscosupplementation Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Viscosupplementation Injection Manufacturers, Product Type & Application
  7. 3.7 Global Viscosupplementation Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Viscosupplementation Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Viscosupplementation Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Viscosupplementation Injection Tier 1, Tier 2, and Tier 3
4 Viscosupplementation Injection Market by Type
  1. 4.1 Viscosupplementation Injection Type Introduction
  2. 4.1.1 Single Injection
  3. 4.1.2 Three Injection
  4. 4.1.3 Five Injection
  5. 4.2 Global Viscosupplementation Injection Sales by Type
  6. 4.2.1 Global Viscosupplementation Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Viscosupplementation Injection Sales by Type (2021-2032)
  8. 4.2.3 Global Viscosupplementation Injection Sales Market Share by Type (2021-2032)
  9. 4.3 Global Viscosupplementation Injection Revenue by Type
  10. 4.3.1 Global Viscosupplementation Injection Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Viscosupplementation Injection Revenue by Type (2021-2032)
  12. 4.3.3 Global Viscosupplementation Injection Revenue Market Share by Type (2021-2032)
5 Viscosupplementation Injection Market by Application
  1. 5.1 Viscosupplementation Injection Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Viscosupplementation Injection Sales by Application
  6. 5.2.1 Global Viscosupplementation Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Viscosupplementation Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Viscosupplementation Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Viscosupplementation Injection Revenue by Application
  10. 5.3.1 Global Viscosupplementation Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Viscosupplementation Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Viscosupplementation Injection Revenue Market Share by Application (2021-2032)
6 Global Viscosupplementation Injection Sales by Region
  1. 6.1 Global Viscosupplementation Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Viscosupplementation Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Viscosupplementation Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Viscosupplementation Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Viscosupplementation Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Viscosupplementation Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Viscosupplementation Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Viscosupplementation Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Viscosupplementation Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Viscosupplementation Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Viscosupplementation Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Viscosupplementation Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Viscosupplementation Injection Revenue by Region
  1. 7.1 Global Viscosupplementation Injection Revenue by Region
  2. 7.1.1 Global Viscosupplementation Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Viscosupplementation Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Viscosupplementation Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Viscosupplementation Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Viscosupplementation Injection Revenue (2021-2032)
  8. 7.2.2 North America Viscosupplementation Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Viscosupplementation Injection Revenue (2021-2032)
  11. 7.3.2 Europe Viscosupplementation Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Viscosupplementation Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Viscosupplementation Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Viscosupplementation Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Viscosupplementation Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Viscosupplementation Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Viscosupplementation Injection Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Anika Therapeutics
  8. 8.2.1 Anika Therapeutics Company Information
  9. 8.2.2 Anika Therapeutics Business Overview
  10. 8.2.3 Anika Therapeutics Viscosupplementation Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Anika Therapeutics Viscosupplementation Injection Product Portfolio
  12. 8.2.5 Anika Therapeutics Recent Developments
  13. 8.3 Seikagaku
  14. 8.3.1 Seikagaku Company Information
  15. 8.3.2 Seikagaku Business Overview
  16. 8.3.3 Seikagaku Viscosupplementation Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Seikagaku Viscosupplementation Injection Product Portfolio
  18. 8.3.5 Seikagaku Recent Developments
  19. 8.4 Zimmer Biomet
  20. 8.4.1 Zimmer Biomet Company Information
  21. 8.4.2 Zimmer Biomet Business Overview
  22. 8.4.3 Zimmer Biomet Viscosupplementation Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zimmer Biomet Viscosupplementation Injection Product Portfolio
  24. 8.4.5 Zimmer Biomet Recent Developments
  25. 8.5 Bioventus
  26. 8.5.1 Bioventus Company Information
  27. 8.5.2 Bioventus Business Overview
  28. 8.5.3 Bioventus Viscosupplementation Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bioventus Viscosupplementation Injection Product Portfolio
  30. 8.5.5 Bioventus Recent Developments
  31. 8.6 Ferring
  32. 8.6.1 Ferring Company Information
  33. 8.6.2 Ferring Business Overview
  34. 8.6.3 Ferring Viscosupplementation Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ferring Viscosupplementation Injection Product Portfolio
  36. 8.6.5 Ferring Recent Developments
  37. 8.7 LG Chem
  38. 8.7.1 LG Chem Company Information
  39. 8.7.2 LG Chem Business Overview
  40. 8.7.3 LG Chem Viscosupplementation Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LG Chem Viscosupplementation Injection Product Portfolio
  42. 8.7.5 LG Chem Recent Developments
  43. 8.8 Freda
  44. 8.8.1 Freda Company Information
  45. 8.8.2 Freda Business Overview
  46. 8.8.3 Freda Viscosupplementation Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Freda Viscosupplementation Injection Product Portfolio
  48. 8.8.5 Freda Recent Developments
  49. 8.9 Haohai Biological
  50. 8.9.1 Haohai Biological Company Information
  51. 8.9.2 Haohai Biological Business Overview
  52. 8.9.3 Haohai Biological Viscosupplementation Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Haohai Biological Viscosupplementation Injection Product Portfolio
  54. 8.9.5 Haohai Biological Recent Developments
  55. 8.10 Shanghai Jingfeng
  56. 8.10.1 Shanghai Jingfeng Company Information
  57. 8.10.2 Shanghai Jingfeng Business Overview
  58. 8.10.3 Shanghai Jingfeng Viscosupplementation Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shanghai Jingfeng Viscosupplementation Injection Product Portfolio
  60. 8.10.5 Shanghai Jingfeng Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Viscosupplementation Injection Value Chain Analysis
  2. 9.1.1 Viscosupplementation Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Viscosupplementation Injection Production Mode & Process
  6. 9.2 Viscosupplementation Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Viscosupplementation Injection Distributors
  9. 9.2.3 Viscosupplementation Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst